Reuters logo
BRIEF-Sinclair Pharma posts FY sales growth of 51 pct
March 21, 2017 / 7:33 AM / in 7 months

BRIEF-Sinclair Pharma posts FY sales growth of 51 pct

March 21 (Reuters) - Sinclair Pharma Plc

* FY sales growth of 51% at £37.8 million, (2015: £25.0 million, 18 months £45.5 million)

* FY gross profit increased 56% to £26.7 million (2015: £17.1 million, 18 months £31.8 million)

* FY adjusted ebitda* loss narrowed to £6.1 million (2015: £8.0 million, 18 months £15.4 million)

* Trading in Q1 2017 in line with management expectations

* Looking ahead, board expects Sinclair to be adjusted EBITDA positive in 2017 - CEO Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below